Readers Questions:
Specific Diagnostic Codes Help You Bill Insulin Inhalation Testing
Published on Tue Aug 18, 2015
Question: A patient recently visited us and enquired about the mandated spirometry tests required for a new insulin inhalation treatment. How should we report these tests? Washington Subscriber Answer: There is indeed an inhaled insulin now available by prescription, a new medication AFREZZA®. The labeling for AFREZZA® mandates spirometry testing (specifically FEV1) to rule out chronic lung disease prior to initiating therapy, [...]